These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR. Guo B; Luo C; Xun C; Xie J; Wu X; Pu J Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416 [TBL] [Abstract][Full Text] [Related]
25. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669 [TBL] [Abstract][Full Text] [Related]
26. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. Dyrskjøt L; Zieger K; Real FX; Malats N; Carrato A; Hurst C; Kotwal S; Knowles M; Malmström PU; de la Torre M; Wester K; Allory Y; Vordos D; Caillault A; Radvanyi F; Hein AM; Jensen JL; Jensen KM; Marcussen N; Orntoft TF Clin Cancer Res; 2007 Jun; 13(12):3545-51. PubMed ID: 17575217 [TBL] [Abstract][Full Text] [Related]
27. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related]
28. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder. Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836 [TBL] [Abstract][Full Text] [Related]
29. Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology. Alameda F; Juanpere N; Pijuan L; Lloveras B; Gimeno J; Baró T; Salido M; Serrano S; Lloreta J Cancer Cytopathol; 2012 Aug; 120(4):276-82. PubMed ID: 22419364 [TBL] [Abstract][Full Text] [Related]
30. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Tilki D; Burger M; Dalbagni G; Grossman HB; Hakenberg OW; Palou J; Reich O; Rouprêt M; Shariat SF; Zlotta AR Eur Urol; 2011 Sep; 60(3):484-92. PubMed ID: 21684071 [TBL] [Abstract][Full Text] [Related]
31. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer. Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139 [TBL] [Abstract][Full Text] [Related]
32. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer. Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419 [TBL] [Abstract][Full Text] [Related]
33. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study. Ribal MJ; Mengual L; Lozano JJ; Ingelmo-Torres M; Palou J; Rodríguez-Faba O; Witjes JA; Van der Heijden AG; Medina R; Conde JM; Marberger M; Schmidbauer J; Fernández PL; Alcaraz A Eur J Cancer; 2016 Feb; 54():131-138. PubMed ID: 26761785 [TBL] [Abstract][Full Text] [Related]
34. UriBLAD: A Urine-Based Gene Expression Assay for Noninvasive Detection of Bladder Cancer. Wang Q; Hu L; Ma W; Meng Z; Li P; Zhang X; Wang Y; Lu Y; Sun Y; Wu Y; Ren W; Song K; Chen J; Wu S; Xu Q; Huang D; Zhang D; Shen Y; Ye D J Mol Diagn; 2021 Jan; 23(1):61-70. PubMed ID: 33122139 [TBL] [Abstract][Full Text] [Related]
35. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Hanke M; Hoefig K; Merz H; Feller AC; Kausch I; Jocham D; Warnecke JM; Sczakiel G Urol Oncol; 2010; 28(6):655-61. PubMed ID: 19375957 [TBL] [Abstract][Full Text] [Related]
36. Gene signatures for the prediction of response to Bacillus Calmette-Guerin immunotherapy in primary pT1 bladder cancers. Kim YJ; Ha YS; Kim SK; Yoon HY; Lym MS; Kim MJ; Moon SK; Choi YH; Kim WJ Clin Cancer Res; 2010 Apr; 16(7):2131-7. PubMed ID: 20233890 [TBL] [Abstract][Full Text] [Related]
37. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses. Garbar C; Mascaux C; Wespes E Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491 [TBL] [Abstract][Full Text] [Related]
38. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193 [TBL] [Abstract][Full Text] [Related]
40. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Wang XS; Zhang Z; Wang HC; Cai JL; Xu QW; Li MQ; Chen YC; Qian XP; Lu TJ; Yu LZ; Zhang Y; Xin DQ; Na YQ; Chen WF Clin Cancer Res; 2006 Aug; 12(16):4851-8. PubMed ID: 16914571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]